Search sponsored by
Amid a flurry of interim results, Lloyds fell short of its dividend objective, while British American Tobacco and AstraZeneca were buoyed by organic growth and product innovation.
MORE ARTICLES ON
Sponsored by Vanguard
Sponsored by Royal London Asset Management
